Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

MicroRNA-216a suppresses the proliferation and migration of human breast cancer cells via the Wnt/β-catenin signaling pathway.

Xie Q, Wang S, Zhao Y, Zhang Z, Qin C, Yang X.

Oncol Rep. 2019 May;41(5):2647-2656. doi: 10.3892/or.2019.7050. Epub 2019 Mar 7.

2.

MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.

Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z, Jiang L, Wang Y, Zong X, Jin F, Wei M.

Tumour Biol. 2016 Apr;37(4):5001-11. doi: 10.1007/s13277-015-4342-x. Epub 2015 Nov 4.

PMID:
26537584
3.

Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5.

Zhang J, Xu K, Shi L, Zhang L, Zhao Z, Xu H, Liang F, Li H, Zhao Y, Xu X, Tian Y.

Oncol Res. 2017 Sep 21;25(8):1317-1327. doi: 10.3727/096504017X14874323871217. Epub 2017 Mar 2.

PMID:
28256193
4.

MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/β-catenin signaling pathway.

Wang Y, Sun S, Xu J, Luo Y, Xin Y, Zhao X.

Oncol Rep. 2018 Feb;39(2):589-596. doi: 10.3892/or.2017.6129. Epub 2017 Dec 4.

PMID:
29207112
5.
6.

MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.

Jiang J, Yang X, He X, Ma W, Wang J, Zhou Q, Li M, Yu S.

Chem Biol Interact. 2019 Apr 1;302:74-82. doi: 10.1016/j.cbi.2019.02.004. Epub 2019 Feb 7.

PMID:
30738779
7.

MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.

Zhao X, Sun S, Xu J, Luo Y, Xin Y, Wang Y.

Oncol Rep. 2018 Aug;40(2):767-774. doi: 10.3892/or.2018.6456. Epub 2018 May 22.

PMID:
29845282
8.

MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.

Liu F, Liu Y, Shen J, Zhang G, Han J.

Oncotarget. 2016 Aug 2;7(31):49130-49142. doi: 10.18632/oncotarget.9734.

9.

MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.

Zhang JQ, Chen S, Gu JN, Zhu Y, Zhan Q, Cheng DF, Chen H, Deng XX, Shen BY, Peng CH.

J Cell Biochem. 2018 Jan;119(1):1027-1040. doi: 10.1002/jcb.26270. Epub 2017 Aug 23.

PMID:
28685847
10.

MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.

Jiang Q, He M, Ma MT, Wu HZ, Yu ZJ, Guan S, Jiang LY, Wang Y, Zheng DD, Jin F, Wei MJ.

Oncol Rep. 2016 Mar;35(3):1425-32. doi: 10.3892/or.2015.4502. Epub 2015 Dec 21.

PMID:
26707142
11.

Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.

Fang Y, Yuan Y, Zhang LL, Lu JW, Feng JF, Hu SN.

Cancer Biomark. 2018;23(3):405-418. doi: 10.3233/CBM-181466.

PMID:
30223390
12.

MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.

Si W, Li Y, Shao H, Hu R, Wang W, Zhang K, Yang Q.

Am J Med Sci. 2016 Aug;352(2):191-9. doi: 10.1016/j.amjms.2016.05.002. Epub 2016 May 7.

PMID:
27524218
13.

5-Acetyl goniothalamin suppresses proliferation of breast cancer cells via Wnt/β-catenin signaling.

Boonmuen N, Thongon N, Chairoungdua A, Suksen K, Pompimon W, Tuchinda P, Reutrakul V, Piyachaturawat P.

Eur J Pharmacol. 2016 Nov 15;791:455-464. doi: 10.1016/j.ejphar.2016.09.024. Epub 2016 Sep 16.

PMID:
27640746
14.

MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.

Cao N, Mu L, Yang W, Liu L, Liang L, Zhang H.

Biomed Pharmacother. 2018 Oct;106:483-490. doi: 10.1016/j.biopha.2018.06.135. Epub 2018 Jul 11.

PMID:
29990836
15.

Mechanism of MicroRNA-708 Targeting BAMBI in Cell Proliferation, Migration, and Apoptosis in Mice With Melanoma via the Wnt and TGF-β Signaling Pathways.

Lu HJ, Yan J, Jin PY, Zheng GH, Zhang HL, Bai M, Wu DM, Lu J, Zheng YL.

Technol Cancer Res Treat. 2018 Jan 1;17:1533034618756784. doi: 10.1177/1533034618756784.

16.

BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling.

Song H, Shi L, Xu Y, Xu T, Fan R, Cao M, Xu W, Song J.

Eur J Pharmacol. 2019 Jun 5;852:189-197. doi: 10.1016/j.ejphar.2019.03.018. Epub 2019 Mar 12.

PMID:
30876979
17.

miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-κB Signaling Pathway.

Wu Y, Zhang J, Zheng Y, Ma C, Liu XE, Sun X.

Oncol Res. 2018 Jan 19;26(1):157-171. doi: 10.3727/096504017X15031557924150. Epub 2017 Aug 23.

PMID:
28835317
18.
19.
20.

MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.

Wang S, Chen X, Tang M.

Oncol Rep. 2014 Dec;32(6):2824-30. doi: 10.3892/or.2014.3478. Epub 2014 Sep 15.

PMID:
25220761

Supplemental Content

Support Center